Professor Bingjie Li is a scholar with extensive expertise in chemistry, clinical medicine, nanotechnology, and biomedical research. He completed advanced studies at renowned institutions, including the University of Oxford and Monash University, specializing in nanotechnology and palliative care, and earned a Ph.D. in Clinical Medicine from Zhengzhou University, where his research focused on inorganic chemistry and translational medicine. Professor Li has made significant contributions to nanotechnology and biomedical research, particularly through pioneering work on innovative nanomaterials for therapeutic applications in cancer and cardiovascular diseases. Linlin Shi is a Professor of Organic Chemistry at Zhengzhou University in Henan. He received his Ph.D. degree in Organic Chemistry from Peking University in 2019 under the supervision of Prof. Zhen Yang and Prof. Jianxian Gong. In 2020, he began his independent academic career at the College of Chemistry at Zhengzhou University. He is working on the total synthesis of anticancer and antibacterial natural products and functional molecules. He has published about 60 SCI papers and co-invented 10 patents. He currently serves as editorial Board Member of Chemical Synthesis, Green Synthesis and Catalysis, Exploration, Chinese Chemical Letters, etc.

• 1. Botanical Overview of the Euphorbiaceae Family2. Isolation and Identification of Natural Products from Euphorbiaceae3. Synthesis of Natural Products from Euphorbiaceae4. Antitumor Activities and Mechanisms of Action of Euphorbiaceae Natural Products5. Antimicrobial Properties and Mechanisms of Action of Euphorbiaceae Natural Products6. Anti-inflammatory Properties and Mechanisms of Action of Euphorbiaceae Natural Products7. Pharmacological properties and Mechanisms of Action of Euphorbiaceae Natural Products8. Drug Discovery Based on Euphorbiaceae Natural Products9. Challenges and Future Directions in Euphorbiaceae-Based Drug Discovery10. Conclusion

Professor Bingjie Li is a scholar with extensive expertise in chemistry, clinical medicine, nanotechnology, and biomedical research. He completed advanced studies at renowned institutions, including the University of Oxford and Monash University, specializing in nanotechnology and palliative care, and earned a Ph.D. in Clinical Medicine from Zhengzhou University, where his research focused on inorganic chemistry and translational medicine. Professor Li has made significant contributions to nanotechnology and biomedical research, particularly through pioneering work on innovative nanomaterials for therapeutic applications in cancer and cardiovascular diseases. Linlin Shi is a Professor of Organic Chemistry at Zhengzhou University in Henan. He received his Ph.D. degree in Organic Chemistry from Peking University in 2019 under the supervision of Prof. Zhen Yang and Prof. Jianxian Gong. In 2020, he began his independent academic career at the College of Chemistry at Zhengzhou University. He is working on the total synthesis of anticancer and antibacterial natural products and functional molecules. He has published about 60 SCI papers and co-invented 10 patents. He currently serves as editorial Board Member of Chemical Synthesis, Green Synthesis and Catalysis, Exploration, Chinese Chemical Letters, etc.

• 1. Botanical Overview of the Euphorbiaceae Family2. Isolation and Identification of Natural Products from Euphorbiaceae3. Synthesis of Natural Products from Euphorbiaceae4. Antitumor Activities and Mechanisms of Action of Euphorbiaceae Natural Products5. Antimicrobial Properties and Mechanisms of Action of Euphorbiaceae Natural Products6. Anti-inflammatory Properties and Mechanisms of Action of Euphorbiaceae Natural Products7. Pharmacological properties and Mechanisms of Action of Euphorbiaceae Natural Products8. Drug Discovery Based on Euphorbiaceae Natural Products9. Challenges and Future Directions in Euphorbiaceae-Based Drug Discovery10. Conclusion

Professor Bingjie Li is a scholar with extensive expertise in chemistry, clinical medicine, nanotechnology, and biomedical research. He completed advanced studies at renowned institutions, including the University of Oxford and Monash University, specializing in nanotechnology and palliative care, and earned a Ph.D. in Clinical Medicine from Zhengzhou University, where his research focused on inorganic chemistry and translational medicine. Professor Li has made significant contributions to nanotechnology and biomedical research, particularly through pioneering work on innovative nanomaterials for therapeutic applications in cancer and cardiovascular diseases. Linlin Shi is a Professor of Organic Chemistry at Zhengzhou University in Henan. He received his Ph.D. degree in Organic Chemistry from Peking University in 2019 under the supervision of Prof. Zhen Yang and Prof. Jianxian Gong. In 2020, he began his independent academic career at the College of Chemistry at Zhengzhou University. He is working on the total synthesis of anticancer and antibacterial natural products and functional molecules. He has published about 60 SCI papers and co-invented 10 patents. He currently serves as editorial Board Member of Chemical Synthesis, Green Synthesis and Catalysis, Exploration, Chinese Chemical Letters, etc.

• 1. Botanical Overview of the Euphorbiaceae Family2. Isolation and Identification of Natural Products from Euphorbiaceae3. Synthesis of Natural Products from Euphorbiaceae4. Antitumor Activities and Mechanisms of Action of Euphorbiaceae Natural Products5. Antimicrobial Properties and Mechanisms of Action of Euphorbiaceae Natural Products6. Anti-inflammatory Properties and Mechanisms of Action of Euphorbiaceae Natural Products7. Pharmacological properties and Mechanisms of Action of Euphorbiaceae Natural Products8. Drug Discovery Based on Euphorbiaceae Natural Products9. Challenges and Future Directions in Euphorbiaceae-Based Drug Discovery10. Conclusion